Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 766

    1.

    Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.

    Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG.

    Ann Intern Med. 2007 May 1;146(9):631-9.PMID: 17470831 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.

    Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, Xu W, Visvanathan S, Rahman MU; Infliximab-GCA Study Group.

    Ann Intern Med. 2007 May 1;146(9):621-30.PMID: 17470830 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.

    Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C, Montecucco C; Systemic Vasculitis Study Group of the Italian Society for Rheumatology.

    Ann Intern Med. 2004 Oct 5;141(7):493-500.PMID: 15466766 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Summaries for patients. Adding infliximab to the treatment regimen for polymyalgia rheumatica.

    [No authors listed]

    Ann Intern Med. 2007 May 1;146(9):I20. No abstract available. PMID: 17470827 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.

    Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel JF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent JD, Pollack PF.

    Ann Intern Med. 2007 Jun 19;146(12):829-38. Epub 2007 Apr 30.PMID: 17470824 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.

    Jover JA, Hernández-García C, Morado IC, Vargas E, Bañares A, Fernández-Gutiérrez B.

    Ann Intern Med. 2001 Jan 16;134(2):106-14.PMID: 11177313 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids.

    Cimmino MA, Salvarani C, Macchioni P, Gerli R, Bartoloni Bocci E, Montecucco C, Caporali R; Systemic Vasculitis Study Group of the Italian Society for Rheumatology.

    Clin Exp Rheumatol. 2008 May-Jun;26(3):395-400.PMID: 18578959 [PubMed - indexed for MEDLINE]Related articles

    8.

    Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

    Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P.

    Lancet. 1999 Dec 4;354(9194):1932-9.PMID: 10622295 [PubMed - indexed for MEDLINE]Related articles

    9.

    Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

    van der Veen MJ, Dinant HJ, van Booma-Frankfort C, van Albada-Kuipers GA, Bijlsma JW.

    Ann Rheum Dis. 1996 Apr;55(4):218-23. Erratum in: Ann Rheum Dis 1996 Aug;55(8):563. PMID: 8733437 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.

    McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T.

    Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. Review.PMID: 17651658 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

    Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, Cohen P, Calabrese LH, Dickler H, Merkel PA, Fortin P, Flynn JA, Locker GA, Easley KA, Schned E, Hunder GG, Sneller MC, Tuggle C, Swanson H, Hernández-Rodríguez J, Lopez-Soto A, Bork D, Hoffman DB, Kalunian K, Klashman D, Wilke WS, Scheetz RJ, Mandell BF, Fessler BJ, Kosmorsky G, Prayson R, Luqmani RA, Nuki G, McRorie E, Sherrer Y, Baca S, Walsh B, Ferland D, Soubrier M, Choi HK, Gross W, Segal AM, Ludivico C, Puechal X; International Network for the Study of Systemic Vasculitides.

    Arthritis Rheum. 2002 May;46(5):1309-18.PMID: 12115238 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).

    Spiera RF, Mitnick HJ, Kupersmith M, Richmond M, Spiera H, Peterson MG, Paget SA.

    Clin Exp Rheumatol. 2001 Sep-Oct;19(5):495-501.PMID: 11579707 [PubMed - indexed for MEDLINE]Related articles

    14.

    A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.

    Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH; Paediatric Rheumatology International Trials Organisation; Pediatric Rheumatology Collaborative Study Group.

    Arthritis Rheum. 2007 Sep;56(9):3096-106.PMID: 17763439 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.

    Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group.

    Arthritis Rheum. 2006 Sep;54(9):2793-806.PMID: 16947627 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial.

    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA.

    Arthritis Rheum. 2008 Feb;58(2 Suppl):S126-35.PMID: 18240203 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.

    Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, Younge BR, Weyand CM, Goronzy JJ.

    Arthritis Rheum. 2006 Oct;54(10):3310-8.PMID: 17009270 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.

    Lémann M, Mary JY, Duclos B, Veyrac M, Dupas JL, Delchier JC, Laharie D, Moreau J, Cadiot G, Picon L, Bourreille A, Sobahni I, Colombel JF; Groupe d'Etude Therapeutique des Affections Inflammatoires du Tube Digestif (GETAID).

    Gastroenterology. 2006 Apr;130(4):1054-61.PMID: 16618399 [PubMed - indexed for MEDLINE]Related articles

    19.

    Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

    Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J.

    Arthritis Rheum. 2005 Apr;52(4):1227-36. Erratum in: Arthritis Rheum. 2005 Sep;52(9):2951. PMID: 15818699 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study.

    Salvarani C, Cantini F, Niccoli L, Catanoso MG, Macchioni P, Pulsatelli L, Padula A, Olivieri I, Boiardi L.

    J Rheumatol. 2003 Apr;30(4):760-3.PMID: 12672196 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data